RxDoctor Payments Data

Marco Perez, MD

Clinical Cardiac Electrophysiology · Stanford, CANPI 1740296607

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $134,275 of the $203,736 with a category attached, or 65.9%. Boston Scientific accounts for 79.4% of it on its own, with 6 other manufacturers making up the rest. 2025 is the largest year on record at $75,601, more than ten times the $1,154 reported in 2019. Among clinical cardiac electrophysiology clinicians in CA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$203,736in general payments, 2019–2025

Across 199 payments — averaging $1023.80 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boston Scientific$162K
  • Biotronik Inc.$23K
  • E.r. Squibb & Sons, L.L.C.$9K
  • Janssen Research & Development, LLC$5K
  • Medtronic$3K
  • Shionogi Inc$2K
  • plus $1K from 1 others
$1,893,579in research payments, 2019–2025

Across 14 payments — averaging $135,256 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Janssen Research & Development, LLC$1.9M

What the payments were for

  • Consulting fees$35,96418%
  • Speaking & faculty fees$134,27566%
  • Travel & lodging$27,87314%
  • Food & beverage$4,8252%
  • Education$8000%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$203,736 in reported general payments places this provider in the 90th percentile of 290 clinical cardiac electrophysiology providers in California.

See all clinical cardiac electrophysiology providers in California

Medicare billing

Part B allowed, 2024
$71,195
Medicare patients
583
Services billed
968

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban62$84,112
XareltoRivaroxaban29$37,785
Dofetilide26$6,524
Nadolol13$968
SotalolSotalol Hcl44$695
Metoprolol Succinate21$293
Flecainide Acetate13$229

Paid to pharmacies, not to this prescriber.

Other clinical cardiac electrophysiology in Stanford

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →